Stats by Source
Total, split by cell line (COSMIC CL / DepMap / PubMed) vs tissue (COSMIC primary tissue)
Total = all mutations for this gene across every source.
Cell line = COSMIC Cell Lines Project + DepMap + PubMed.
Tissue = COSMIC primary-tissue (patient tumour) samples.
Total can exceed cell line + tissue: COSMIC tissue-derived models sit only in global, and a peptide can be shared across both.
| Total | Cell line | Tissue | |
|---|---|---|---|
| Mutations | 6,594 | 701 | 5,868 |
| Samples | 1,206 | 205 | 996 |
| Peptides | 1,003 | 154 | 884 |
Function
CRB1 · Crumbs cell polarity complex component 1
This gene encodes a protein which is similar to the Drosophila crumbs protein and localizes to the inner segment of mammalian photoreceptors. In Drosophila crumbs localizes to the stalk of the fly photoreceptor and may be a component of the molecular scaffold that controls proper development of polarity in the eye. Mutations in this gene are associated with a severe form of retinitis pigmentosa, RP12, and with Leber congenital amaurosis. Alternate splicing results in multiple transcript variants, some protein coding and some non-protein coding.[provided by RefSeq, Apr 2012].
Isoforms & Proteins
6 transcripts · UniProt mapping is sequence-verified (AA-safe)
Each Ensembl transcript (ENST) this gene is mutated on, with its matched UniProt accession.
The mapping is sequence-verified: the UniProt sequence is identical to the transcript translation, so amino-acid positions line up exactly. A * marks an unreviewed (TrEMBL) entry.
Counts are mutations and unique mutant peptides on each transcript.
Gene Properties
Recurrent Mutations
All 906 amino-acid changes on canonical ENST00000367400 · needle height = samples · drag the mini-map to zoom
A lollipop / needle plot – the standard way to show recurrent mutations along a protein (as used by cBioPortal and MutationMapper).
X-axis = amino-acid position in the protein.
Needle height & head size = how often that exact amino-acid change was observed (its recurrence). Tall/large heads are mutational hotspots.
The most recurrent changes are labelled; hover any needle for the change, position and counts.
Mutation frequency across cancer types
% of samples with a missense/complex mutation in CRB1 · cell line vs tissue
For each cancer type, the fraction of samples that carry at least one missense/complex mutation anywhere in CRB1 – counted as distinct samples (a sample counts once no matter how many mutations it has).
Split into cell line and tissue; each cell shows mutated / total and the percentage. Cohorts with <20 samples are omitted. Ordered by combined frequency.
| Cancer type | Cell lines | Tissue samples |
|---|---|---|
| Chronic Myelogenous Leukemia | 3/25 12% | 0/0 0% |
| Melanoma | 22/210 10% | 225/1899 12% |
| Squamous Cell Lung Carcinoma | 5/57 9% | 70/810 9% |
| Non-Small Cell Lung Carcinoma | 41/304 13% | 102/1390 7% |
| Endometrial Carcinoma | 6/42 14% | 46/612 8% |
| Glioblastoma | 7/98 7% | 0/0 0% |
| T-Lymphoblastic Leukemia | 2/40 5% | 0/0 0% |
| Other Solid Cancers | 3/94 3% | 63/1515 4% |
| Small Cell Lung Carcinoma | 0/9 0% | 30/752 4% |
| T-Cell Non-Hodgkins Lymphoma | 1/26 4% | 0/0 0% |
| Oral Cavity Carcinoma | 2/54 4% | 0/0 0% |
| Colorectal Carcinoma | 22/143 15% | 96/3239 3% |
| Esophageal Carcinoma | 2/23 9% | 25/769 3% |
| Gastric Carcinoma | 2/74 3% | 61/1809 3% |
| Hodgkins Lymphoma | 2/16 12% | 2/122 2% |
| Neuroendocrine Tumour | 17/154 11% | 4/577 1% |
| Germ Cell Tumour | 2/25 8% | 3/169 2% |
| Cervical Carcinoma | 4/35 11% | 7/422 2% |
| Osteosarcoma | 4/45 9% | 1/166 1% |
| Head and Neck Carcinoma | 3/85 4% | 33/1574 2% |
| Ovarian Carcinoma | 7/109 6% | 15/998 2% |
| Bladder Carcinoma | 0/58 0% | 20/956 2% |
| Esophageal Squamous Cell Carcinoma | 2/51 4% | 44/2550 2% |
| Adrenocortical Carcinoma | 2/3 67% | 0/112 0% |
| Breast Carcinoma | 17/144 12% | 31/3264 1% |
| Hepatocellular Carcinoma | 0/46 0% | 29/2210 1% |
| Other Sarcomas | 3/69 4% | 6/699 1% |
| Acute Myeloid Leukemia | 1/90 1% | 0/0 0% |
| Biliary Tract Carcinoma | 1/54 2% | 8/950 1% |
| Burkitts Lymphoma | 2/32 6% | 0/196 0% |
Mutation Distribution
Where CRB1 is mutated · all tissues, split by cell line vs tissue
How many mutations in CRB1 were found in each tissue, across the whole database.
Each bar is a tissue (cell-line and tissue names are merged to the standard tissue), split into cell line and tissue (patient tumour) contributions.
This shows the cancer-context where this gene is recurrently altered.
GTEx Expression
Median TPM across 54 healthy tissues
Median gene expression (TPM) in normal, non-cancer human tissues from the GTEx project.
Useful for judging tumour specificity – a strong neoantigen target ideally comes from a gene with low expression in healthy tissues.
Scroll or drag the mini-axis below the chart to browse all tissues.
Mutations
All 6,594 mutations in CRB1
Every mutation record for this gene, across all samples and sources.
The Sample column links to the cell line (cell-line samples) or the tissue type (tissue samples).
Use the Type / Source filters, the search box, and column sorting to explore; each CAN-IMMUNE ID opens the full mutation & peptide view.
| ID | Sample | Transcript | AA Change | CDS | Type | Source | Mutant Peptide | Wild-type Peptide |
|---|